Twenty-four monoclonal antibodies (MAbs) against rinderpest virus (RPV) were established and characterized by several serological tests. Of the 24 MAbs, 10 recognized the nucleoprotein (NP), six the phosphoprotein (P), four the haemagglutinin (H), and two the fusion (F) protein as determined by radioimmunoprecipitation assay. The specificities of the remaining two MAbs could not be determined. From a competitive binding assay using MAbs against each structural protein, at least five, four and two separate antigenic sites were identified on the NP, P and H proteins, respectively. MAbs against the H protein neutralized the infectivity of the virus, but those against the F protein were only neutralizing in the presence of guinea-pig complement. The reactivities of each of the MAbs for other strains of morbillivirus were tested using an indirect immunofluorescent antibody assay. The MAbs against four out of five antigenic sites on the NP showed cross-reactivity amongst all the strains of morbillivirus tested whereas the fifth antibody reacted only with RPV. Of the antibodies specific for the P protein, the antibody against one site was cross-reactive with all the strains of RPV, measles virus (MV) and canine distemper virus (CDV), the antibody against another site was reactive with RPV and MV but not with CDV, and the antibodies against the other two sites were specific for RPV.
INTRODUCTION
Rinderpest virus (RPV) is classified as a member of the genus morbillivirus of the family Paramyxoviridae, which includes measles virus (MV), canine distemper virus (CDV) and peste des petits ruminants virus (PPRV). It has been shown that morbilliviruses have at least six major structural proteins: phospho-(P), nucleo-(NP), large (L), haemagglutinin (H), fusion (F) and matri~ (M) proteins, and post-translational modification of some of these polypeptides has been demonstrated (Bussell et al., 1974; Mountcastle & Choppin, 1977; Hall et al., 1980; Rima, 1983) . Several investigators have analysed polypeptides of RPV in infected cells (Prakash et al., 1979; Sato et al., 1981; Diallo et al., 1987; Grubman et al., 1988) , but the data in these reports are contradictory.
Antigenic correlations between morbilliviruses have been demonstrated by various serological tests such as virus neutralization (VN), immunofluorescent antibody, complement fixation and haemagglutination inhibition tests (Imagawa, 1968; Orvell & Norrby, 1974) . Monoclonal antibodies (MAbs) against MV and CDV polypeptides have been used for comparison of antigens of MV, CDV and RPV (Norrby et aL, 1985; Sheshberadaran et al., 1986) , and it was suggested that RPV may be the archevirus of the morbillivirus group. However, MAbs against RPV have been used only in a recent antigenic analysis of seal morbillivirus (Cosby et al., 1988) .
In this study, we have isolated 24 MAbs against RPV. They were all shown to be directed against four structural components (H, P, NP and F), except two antibodies whose antigenic specificities could not be determined. The cross-reactivity of each of these antibodies with other morbilliviruses was also examined.
METHODS
Viruses. The lapinized (L) strain at the 13th passage level (Ishii et al., 1986) and the LA strain of RPV were used for production of MAbs. Four attenuated strains (FXNO, Hg, YSA and Hk) and two virulent strains (Snyder Hill and Nakano) of CDV, three strains of MV consisting of one laboratory strain (Edmonston), an attenuated strain (AIK-C) and fresh isolate from a measles patient (Ebihara), and two strains of subacute sclerosing panencephalitis virus (Mantooth and Yamagata-1) were used in the indirect immunofluorescent antibody (IFA) test. All of these viruses were propagated in Vero cells. For the radioimmunoprecipitation assay (RIPA), the L strain of RPV was propagated in NA cells, a mouse neuroblastoma cell line.
Preparation of MAbs against RPV. RPV-infected Vero cells showing 80 to 90~ c.p.e, were harvested, frozen and thawed, sonicated at 20 kHz for 30 s and clarified by centrifugation at 6000 r.p.m, to prepare immunizing materials. The technique for the production of MAbs was similar to that described previously (Sugiyama et al., 1989) . Briefly, spleen cells obtained from RPV-immunized BALB/c mice were fused with P3-X63-Ag-U 1 or X63-Ag8-653 myeloma cells using polyethylene glycol. The hybridoma cells were screened for antibody activity against RPV by an indirect immunoperoxidase (liP) test. The positive cells were cloned by the limiting dilution method and inoculated intraperitoneally into pristane-primed BALB/c mice to collect antibody-rich ascitic fluids. The isotypes of the MAbs were determined by testing the hybridoma culture fluids using a commercial ELISA kit (Zymed Laboratories).
RIPA. When about 80~ of the NA cell monolayer showed c.p.e., the cells were incubated in methionine-free Eagle's MEM for 1 h and then labelled with 20 pCi/ml [35S]methionine (ICN Radiochemicals) for 2 h. RIPA was performed as described previously (Hirayama et al., 1985) . Electrophoresis was carried out as described by Laemmli (1970) using a 10~ polyacrylamide gel and a loading buffer with or without 2-mercaptoethanol (2-ME).
Competitive binding assay. IgG antibodies precipitated by ammonium sulphate from the ascitic fluid were labelled with biotin by the method of Shaw et al. (1986) . The unlabelled MAbs were fourfold serially diluted starting from the dilution which corresponded to four times the dilution giving an optical density (O.D.) of 1.0 in the IIP test, and each 0.05 ml was put on RPV strain L-infected cells in the wells of microplates. After a 30 min incubation at 37 °C, 0.025 ml of the biotinylated MAb diluted to an approximate O.D. of 1.0 was added to each well and allowed to bind for 30 min at 37 °C. The plate was washed five times in 0-15~ Tween-20-phosphatebuffered saline and the assay was processed with peroxidase-streptavidin (Zymed Laboratories) and ophenylenediamine. The competition was determined to be positive when the dilution of the unlabelled antibody required for 70 9/00 inhibition was less than four times the dilution of the unlabelled antibody necessary to inhibit the homologous biotinylated antibody to a similar extent.
Serological tests. VN and complement-required neutralization (CRN) tests on the L strain of RPV were carried out by plaque assay on Vero cells. In brief, 0-05 ml of serial twofold dilutions of inactivated ascitic fluid were mixed with an equal volume of the virus suspension containing approx. 50 p.f.u./0.5 ml and incubated at 4 °C overnight. Then 0.1 ml of the virus-antibody mixture was inoculated onto the cell monolayer in a 24-well plate. After adsorption for 60 min at 37 °C, each culture received 1 ~ methyl cellulose medium, and virus-induced plaques were counted by adding 0.017 9/o neutral red 4 days later. The neutralizing antibody titres were expressed as reciprocals of the highest ascitic fluid dilution causing a 70~ reduction in plaque counts. The procedures for the CRN tests were similar to those described above for the VN test except for the addition of a 1 : 10 dilution of fresh guinea-pig serum to the virus-antibody mixture at a ratio of 1:2 and the inoculation of cells with 0.15 ml of this mixture per well.
1FA tests. Vero cells grown on a heavy Teflon-coated slide (Bokusui Brown) were infected with various strains of morbilliviruses. When the c.p.e, developed to a moderate degree, the ceils were fixed with a mixture of 50~ acetone and 50~ methanol for 10 min at -20 °C. Serial fourfold dilution of ascitic fluids from 1 : 100 were added, and then reacted with fluorescein-conjugated anti-mouse IgG (ICN Immuno Biochemicals). For the membrane IFA (mlFA) test using RPV strain L-infected living cells, the cells were trypsinized and single cells were mixed with a 1 : 100 dilution of the ascitic fluid in a 1.5 ml microtube. After incubation at 37 °C for 40 min, the cells were washed by centrifugation at 3000 r.p.m, for 1 min, and treated with fluorescein-conjugated anti-mouse IgG.
RESULTS

Specificity of MAbs
A total of 24 hybridomas producing MAbs against RPV protein were isolated. The specificity of these MAbs was determined by RIPA. Results from a representative subset of MAbs are shown in Fig. 1 proteins of Mr 74K, 72K 62K or 44K under reducing conditions with 2-ME (Fig. 1) . Two antibodies failed to react with any of the viral proteins. The proteins of Mr 62K, 44K and 40K corresponded to the NP, F1 and M proteins, respectively, in accordance with the data relating to the LA strain of R P V described previously (Sato et al., 1981) . To identify the other viral structural proteins, two MAbs were compared with RPV-infected rabbit serum and hyperimmunized mouse serum under both reducing and non-reducing conditions. It is known that the F protein of morbilliviruses consists of the disulphide-linked subunits, F1 and F2, and the H protein also exists in a polymeric disulphide-linked form. As shown in Fig. 2 , the 72K and 62K proteins were in the same form whereas under reducing and non-reducing conditions, the 74K and 44K proteins have higher Mrs (over 130K and 62K respectively) under non-reducing conditions. Moreover, the antibodies reacting with the latter two bands in RIPA showed positive fluorescence on the RPV-infected cell surface in the mlFA test. On the basis of these findings, the four bands were considered to correspond to H (74K), P (72K), NP (62K) and F1 (44K), respectively. Thus, four MAbs (1 ld, S-l, 17b, ld) were considered to be specific for the H protein, six (H21, U32, W21,032, R23, 2-1) for the P protein, 10 (M22, N21, Kll, P31, Gll, C22, D12, Q24, B11, Y13) for the NP protein, and two (2a, 7-1) for the F1 protein. Two MAbs (2-1, 7-1) are directed against the LA strain and the other antibodies against the L strain.
Characterization of the antigenic sites on the NP, P and H proteins by a competitive binding assay Twenty MAbs recognizing the NP, P or H protein were purified and used to examine antigenic sites on the proteins in a competitive binding assay. Representative results for the six NP-specific MAbs are shown in Fig. 3 . The biotinylated antibody B11 competed effectively with an unlabelled homologous antibody, but not with any of the other five antibodies (Fig. 3 a) . The biotinylated antibody M22 competed not only with homologous antibody but also significantly with MAb N21 (Fig. 3b) .
The results of the competitive binding assay are summarized in Tables 1, 2 and 3. All of the purified MAbs significantly inhibited the binding of homologous biotinylated antibodies. By testing heterologous combinations, the NP, P and H proteins could be assigned at least five, four and two antigenic sites, respectively. Antigenic sites I (NP-I) and II (NP-II) on the NP protein overlapped with the site recognized by MAb K11. The competition was not always reciprocal, one-way competition being observed among the NP-II antibodies (Table 1) and the H-I antibodies (Table 3) .
On: Sun, 06 Jan 2019 09:14:11 Table 5 . Biological activities of MAbs Antibody activities determined by mIFA, VN and CRN tests are summarized in Table 4 . mIFA activity, seen as capping on the cell surface, was found in all the antibodies against the H and F1 proteins, but in none of the MAbs against the NP and P proteins and the MAbs with undetermined specificity. All of the MAbs against the H protein had VN activity, this activity being higher in the MAbs reacting with site H-I than in those reacting with site H-II. Two MAbs against the F1 protein had no VN activity but showed a high CRN activity. Neither VN activity nor CRN activity was found in the MAbs against NP and P nor in the antibodies of undetermined specificity.
MAbs against RPV proteins
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Cross-reactivity* of anti-RPV MAbs with various strains of morbillivirus~ in IFA
Immunoreactivity of MAbs with various strains of morbillivirus
All 24 MAbs were examined for their cross-reactivity with various strains of morbillivirus using an IFA test (Table 5) . Two MAbs, l ld specific for the H protein and Z25 with undetermined specificity, failed to react with the LA strain of RPV, whereas the remaining MAbs reacted with both strains of RPV. Nine antibodies against NP antigenic sites I, II, III and IV, cross-reacted with all the MV and CDV strains tested, whereas the antibody against NP antigenic site V failed to cross-react with any of these strains. The anti-P MAbs showed three different patterns of cross-reactivity. The MAbs against antigenic sites P-I and P-II reacted only with RPV, those against P-III cross-reacted with all the MV strains tested, and the single antibody against P-IV cross-reacted with all the morbilliviruses tested. The MAbs against antigenic site H-I failed to cross-react. Of the two antibodies against antigenic site H-II, antibody 17b cross-reacted with three strains of CDV but antibody ld failed to cross-react. Of two antibodies against the F1 protein, antibody 2a cross-reacted with the Ebihara strain of MV only, but antibody 7-1 failed to cross-react. One of the two antibodies with undetermined specificity cross-reacted with all the MV strains tested but the other failed to cross-react. DISCUSSION A total of 22 MAbs reacting with either the H, P, NP or F1 proteins were obtained. The remaining two antibodies failed to precipitate viral protein. It was confirmed that these antibodies could bind to Protein A by immunostaining using Protein A-horseradish peroxidase (E Y Laboratories) (data not shown). The antigenic epitopes concerned may have lost their antigenicity due to structural changes caused by the detergents. In vitro translated proteins which are unaffected by detergents might be useful as an antigen in RIPA. A MAb against the M protein was not obtained. It is possible that the M protein of RPV has a low immunogenicity in BALB/c mice.
By competitive binding assays, non-reciprocal interactions were found in antigenic sites NP-I, NP-II and H-I. These interactions were similar to those previously noted for influenza virus and MV (Lubeck & Gerhard, 1981; Sato et al., 1985) .
The NP protein appears to be the most antigenically stable viral protein, because four out of five antigenic sites were completely conserved among the morbillivirus strains. The amino acid sequences deduced from the nucleotide sequences of the NP protein of MV and CDV were reported to be highly conserved except for 100 amino acids at the carboxyl end (Rozenblatt et al., 1985) . Moreover our recent data on the NP sequence of RPV showed a high level of homology in the NP of MV, CDV and RPV strains (H. Kamata et al., unpublished results) . The results of this study agree with these findings and extend them to at least four highly conserved sites among the three morbilliviruses.
The P protein of three morbilliviruses appears to have distinct epitopes by the IFA test. One MAb (R23) against epitope P-Ill cross-reacted with all the strains of MV but not with CDV. Norrby et al. (1985) have proposed that RPV is the archevirus of the morbiUivirus group and that CDV branched from RPV earlier than MV. A pattern of cross-reaction similar to that of antibody R23 was observed for one of the MAbs (E 11) with undetermined specificity. This may support the proposal of Norrby et al. (1985) , since the antigenic relationship between RPV and MV seemed to be closer than that between RPV and CDV. However, antibody 17b which recognizes the H protein, cross-reacted with CDV but not with MV. Therefore, epitope analysis and gene analysis are required to determine more precisely the phylogeny of these viruses.
The MAbs recognizing the same antigenic sites on the H protein showed different crossreactivity with the other morbillivirus strains. These antibodies might be directed to a slightly different epitope within the same antigenic site. It is interesting that a one-way cross-reaction in the competitive binding assay was observed between the two anti-H MAbs, 1 ld and S-I, both of which showed high VN titres. It seems likely that physical hindrance or allosteric change occurred on the H-I Site by binding with an antibody. These MAbs against the H-I site may be useful in elucidating the mechanisms for the VN of the morbilliviruses.
Recently, the amino acid sequences deduced from the nucleotide sequences of the F protein of RPV, MV and CDV strains and the H protein of RPV and MV strains have been compared (Tsukiyama et al., 1987 (Tsukiyama et al., , 1988 Hsu et al., 1988; Yamanaka et al., 1988) . The F protein of RPV was shown to be more conserved than the H protein and to be more closely related to MV than to CDV. Similar results were reported using MAbs against the F and H proteins of MV and CDV (Norrby et al., 1985 , Sheshberadaran et al., 1986 . Nevertheless, the anti-H or -F MAbs obtained in the present study failed to show cross-reactivity with the other morbilliviruses. Production of MAbs against H or F protein is in progress to analyse the epitopes and the function of these proteins more completely.
